Johan Heylen
Chief Executive Officer presso Sanofi Belgium NV
Profilo
Johan Heylen is currently the Director at FlandersBio vzw and the Managing Director at Sanofi Belgium NV.
He previously worked as the Executive Director-Global Commercial at GSK Plc from 2007 to 2011 and as the Chief Commercial Officer at Ablynx NV.
Mr. Heylen received his undergraduate degrees from Katholieke Universiteit Leuven, Hogeschool-Universiteit Brussel, and Solvay Business School of Economics & Management.
Posizioni attive di Johan Heylen
| Società | Posizione | Inizio |
|---|---|---|
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Director/Board Member | - |
Sanofi Belgium NV
 Sanofi Belgium NV BiotechnologyHealth Technology Part of Sanofi, Sanofi Belgium NV is a Belgian company that produces and markets biological drugs. The private company is based in Diegem, Belgium. The company was founded in 1998. The CEO is Johan Heylen. | Chief Executive Officer | - |
Precedenti posizioni note di Johan Heylen
| Società | Posizione | Fine |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01/01/2011 |
| ABLYNX | Corporate Officer/Principal | - |
Formazione di Johan Heylen
| Katholieke Universiteit Leuven | Undergraduate Degree |
| Hogeschool-Universiteit Brussel | Undergraduate Degree |
| Solvay Business School of Economics & Management | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GSK PLC | Health Technology |
| Aziende private | 3 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Commercial Services |
Sanofi Belgium NV
Sanofi Belgium NV BiotechnologyHealth Technology Part of Sanofi, Sanofi Belgium NV is a Belgian company that produces and markets biological drugs. The private company is based in Diegem, Belgium. The company was founded in 1998. The CEO is Johan Heylen. | Health Technology |
- Borsa valori
- Insiders
- Johan Heylen
